The aging population is the greatest social, medical and economic challenge of the 21st century. People worldwide are living longer, a triumph of technology, yet longer lifespans result in a dramatic increase in age-related conditions, like cancer, type II diabetes, cardiovascular diseases and neurodegenerative diseases. Age-related diseases are, in fact,the major killers in the world.
Research aiming to improve life and health in old age has an unparalleled potential. We now know it is possible to retard the process of aging in animal models, extend healthy years of life, and prevent diseases. Genetic manipulations, diet and drugs can be used to slow down aging. Whoever can translate these remarkable discoveries in animals to humans will forever change humankind.
In the top 10 disruptive technologies to invest in, according to Citibank.
"Our future economy, society and politics will be shaped by the attempt to overcome death." - Yuval Noah Harari
The longevity economy is projected to reach $27 trillion in 2026.
According to Bank of America, the market to delay death is expected to be worth at least $600 billion by 2025.
Providing bioinformatics and statistical support for big data analysis and interpretation.
Developing supplements and optimizing diets for health and longevity.
Advising clients on how the discovery, optimization and pre-clinical validation of longevity drugs.
Designing clinical studies and defining endpoints for obtaining regulatory approval.